doi: 10.1128/AAC.31.1.132.
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid
- PMID: 3105441
- PMCID: PMC174671
- DOI: 10.1128/AAC.31.1.132
Item in Clipboard
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid
Antimicrob Agents Chemother.
1987 Jan.
Abstract
The in vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae (M. chelonei) to ticarcillin in combination with calvulanic acid (CA) was studied by the agar dilution method. All the M. tuberculosis, M. bovis, and M. africanum strains were inhibited at a ticarcillin concentration of 32 micrograms/ml or lower in combination with 5 micrograms of CA. M. chelonae and M. avium strains proved resistant to more than 128 micrograms of ticarcillin plus 5 micrograms of CA per ml. M. fortuitum strains needed 128 micrograms of ticarcillin plus 5 micrograms of CA to inhibit approximately 30% of the isolates.
Similar articles
-
In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid.J Antimicrob Chemother. 1988 Dec;22(6):863-6. doi: 10.1093/jac/22.6.863. J Antimicrob Chemother. 1988. PMID: 3149633
-
In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.Curr Med Res Opin. 1984;9(3):157-60. doi: 10.1185/03007998409109575. Curr Med Res Opin. 1984. PMID: 6568146
-
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.Eur J Clin Microbiol. 1986 Aug;5(4):453-4. doi: 10.1007/BF02075706. Eur J Clin Microbiol. 1986. PMID: 3093225 No abstract available.
-
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.Antimicrob Agents Chemother. 1984 Mar;25(3):392-4. doi: 10.1128/AAC.25.3.392. Antimicrob Agents Chemother. 1984. PMID: 6721472 Free PMC article.
-
[Current antimicrobial agent series II: Ticarcillin].Jpn J Antibiot. 1988 Jul;41(7):761-81. Jpn J Antibiot. 1988. PMID: 3050182 Review. Japanese. No abstract available.
Cited by
-
Overexpression, purification and biochemical characterization of a class A high-molecular-mass penicillin-binding protein (PBP), PBP1* and its soluble derivative from Mycobacterium tuberculosis.Biochem J. 2002 Feb 1;361(Pt 3):635-9. doi: 10.1042/0264-6021:3610635. Biochem J. 2002. PMID: 11802794 Free PMC article.
-
Pharmacokinetic factors in the modern drug treatment of tuberculosis.Clin Pharmacokinet. 1999 Aug;37(2):127-46. doi: 10.2165/00003088-199937020-00003. Clin Pharmacokinet. 1999. PMID: 10496301 Review.
-
Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.Antimicrob Agents Chemother. 1998 Jun;42(6):1524-6. doi: 10.1128/AAC.42.6.1524. Antimicrob Agents Chemother. 1998. PMID: 9624510 Free PMC article.
-
The Mycobacterium avium complex.Clin Microbiol Rev. 1993 Jul;6(3):266-310. doi: 10.1128/CMR.6.3.266. Clin Microbiol Rev. 1993. PMID: 8358707 Free PMC article. Review.
-
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.Antimicrob Agents Chemother. 1995 Jul;39(7):1454-7. doi: 10.1128/AAC.39.7.1454. Antimicrob Agents Chemother. 1995. PMID: 7492084 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
